pharma · Atopic Dermatitis
Organon Pharma Pty
Organon Pharma Pty Ltd
Organon Asia Pacific is a pharma organization headquartered in SG. Primary therapeutic focus areas include Atopic Dermatitis. NovaPharmaNews links 1 clinical program(s), 6 drug profile(s), and 0 patent record(s) to this
SG HQ
2021 Founded
41 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- SG
- Founded
- 2021
- Employees
- 41
- Programs
- 1
- Drugs
- 6
- Patents
- 0
E6005
Phase 2 · small molecule · Atopic Dermatitis
E6005 for Atopic Dermatitis is a Phase 2 program (small_molecule) at Organon Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code E6005-J081-101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Organon Pharma Pty Ltd
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Atopic Dermatitis
- Status
- completed
- Trials
- 1